* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Ketaset-Rompun Anesthesia Induces a Conditioned Taste Aversion
Survey
Document related concepts
Transcript
474 METZGER ET AL. associated with administration of Ketaset-Rompun, many researchers have adopted the use of this anesthetic for surgical and/or analgesic purposes in rodent preparations. However, despite the recent popularity of Ketaset-Rompun anesthesia, there have been few investigations examining the behavioral effects of this drug. Several investigations have been reported for effects of anesthetics other than Ketaset-Rompun, but the results have been mixed. Rabin and Rabin (1984) investigated whether a conditioned taste aversion (eTA) (Le., a rejection of a novel flavor after that flavor is paired with an illnessinducing substance) would occur under Pentobarbital anesthesia. Of particular interest in this experiment was a control group that was presented with a novel sucrose solution, immediately anesthetized with Pentobarbital, and maintained under a surgical plane of anesthesia for 47 hr. When tested for an aversion 1 day later, rats in this group did not demonstrate a eTA for the sucrose solution, whereas rats that were anesthetized and further administered radiation or lithium-chloride did show the eTA effect. This result suggests that Pentobarbital itself did not produce a eTA, and also indicates that anesthetization with Pentobarbital did not attenuate the induction of eTA. Additionally, Aguado, San Antonio, Perez, Del Valle, & Gomez (1994) examined whether the administration of Ketaset prior to conditioning would retard the acquisition of gustatory learning. One result from this study was that administration of Ketaset prior to conditioning impaired one-trial learning of an aversion to sucrose with a eTA paradigm (for similar results, see Welzl, Alessandri, & Battig, 1990). These results suggest that administration of certain anesthetic agents do not produce eTA, and they also indicate that certain anesthetic agents may in fact interfere with learning of taste aversions. In contrast to studies that report a failure to obtain taste aversions with anesthetics, other investigations have reported that administration of anesthetics can induce weak aversions to novel flavors. BureSova and BureS (1977) investigated the effect of Allobarbital anesthesia on eTA in rats and reported that injections of this anesthetic following consumption of a novel saccharin solution produced a weak eTA effect. Similarly, Bermudez-Rattoni, Forthman, Sanchez, Perez, and Garcia (1988) reported that administration of Rompun produced a mild aversion to tomato juice when injected after consumption of the novel flavor. These results, in contrast to those reported by Rabin and Rabin (1984) and Aguado et al. (1994), suggest that certain types of anesthetics may induce mild taste aversions if paired with a novel flavor. The aim of the present study was to examine further the effects of an anesthetic (Ketaset-Rompun) as the conditioning agent (US) in the eTA paradigm. As Ketaset-Rompun has recently become popular for use in rodent surgical preparations, the methodological implications for investigators using this drug within the eTA paradigm would be of potential importance, particularly if the anesthetic itself produces aversion to novel flavors. Experiment 1 examined whether Ketaset- 476 M e d i a n 0 METZGER ET AL. 4 2 e 0 e n c e -2 S c 0 r -4 e SAL ANES Figure 1. Median difference scores (test ml - train ml) for animals in the SAL and ANES groups in Experiment 1. (Error bars =semi-interquartile range) minus the amount consumed at training) and were used as the dependent measure. Results and Discussion Because of skewed distributions, nonparametric Kruskal-Wallis ANOVAs and Mann-Whitney U tests were computed to detect any differences between the groups in these experiments. (Figure 1 presents the median difference scores of the SAL and ANES group on the 24-hr retention test.) The amount of sucrose consumed by the CTRL and ANES groups on the conditioning day did not reliably differ, as confirmed by statistical analysis (U = 44.5, P > .10). However, there were clear differences in the amount of sucrose intake between the groups on the 24-hr retention test. As seen in Figure 1, following testing the ANES group demonstrated reliably lower difference scores compared to the SAL group, suggesting that administration of Ketaset-Rompun anesthesia resulted in an aversion to the sucrose solution at testing. These impressions were confirmed by statistical analysis, as a MannWhitney U test computed on the difference scores yielded a significant treatment effect (U = 16, P < .02). Experiment 2 Whereas Experiment 1 demonstrated that immediate injections of the Ketaset-Rompun anesthetic produced a reliable CTA, Experiment 2 sought to further examine this effect. One characteristic of CTA learning is that the strength of the aversion decreases as the time interval 478 METZGER ET AL. consumed was recorded to the nearest ml. Following sucrose consumption, animals in the SAL (n = 9) and AN-O (n = 6) groups received immediate injections of bacteriostatic water or anesthesia, respectively. The remaining groups were injected with the anesthetic after delays of 1 hr (AN-1; n = 9), 2 hr (AN-2; n = 9), 4 hr (AN-4; n = 9), or 6 hr (AN-6; n = 7). The volume, ratio of stock/vehicle, and route of administration for the anesthesia groups was identical to that described in Experiment 1. All subjects were tested for an aversion to the sucrose solution 24 hr after the beginning of conditioning, and the amount consumed was recorded to the nearest ml. As in Experiment 1, difference scores were computed to account for variability between the subjects on fluid intake. Results and Discussion A Kruskal-Wallis one-way ANOVA indicated that there were no differences among the groups on the amount of sucrose consumed on the conditioning day (H = 7.52, P > .05). However, subsequent planned comparisons indicated that there were reliable differences in the difference scores between the groups after testing. Planned comparisons using Mann-Whitney U tests confirmed that the difference scores of the AN-O (U = 9; P < .05), AN-1 (U = 18.5, P < .05), and AN-2 (U = 8, P < .05) groups were reliably lower than the scores of the group injected with saline (SAL) on the conditioning day, suggesting that rats injected with the anesthetic up to 2 hr after presentation of the CS demonstrated CTA. However, the groups injected with the anesthetic either 4 (AN-4; U = 20.5, p> .05) or 6 hr (AN-6; U = 18.5, p> .05) after sucrose consumption exhibited difference scores similar to those of the saline-injected group. Additionally, subsequent analysis indicated that the 2-hr delay group demonstrated the largest CTA, as the AN-2 group reliably differed from both the AN-O (U = 10.5, P < .05) and the AN-1 (U = 7.5, P < .05) groups. Figure 2 presents the median difference scores for the immediate and delay groups in Experiment 2. General Discussion This study consisted of two experiments that used Ketaset-Rompun anesthesia as the conditioning agent in the CTA paradigm. Experiment 1 demonstrated that rats injected with the anesthetic immediately after the presentation of a novel sucrose solution consumed reliably less sucrose than control rats on a 24-hr retention test. Additionally, Experiment 2 showed that, when compared to the control group, anesthetic-injected animals demonstrated CTA if the CS-US interval was either immediate, 1 hr, or 2 hr, whereas no CTA was evident when the CS-US interval was lengthened to 4 or 6 hr. Taken together, the results of these experiments suggest that injections of Ketaset-Rompun anesthesia can produce aversions to novel flavors and that these aversions can occur with CSUS intervals of at least 2 hr. ANESTHESIA AND CONDITIONED TASTE AVERSION 479 The results of this study are similar to earlier reports of the induction of a CTA when different anesthetics were used as the conditioning agents, and the present study replicates and extends these findings to a different class of anesthetic (Ketaset-Rompun). BureSova and BureS (1977) have reported that Allobarbitol anesthesia produces a CTA, and Bermudez-Rattoni et al. (1988) have reported similar effects with Rompun alone. Although this study utilized different anesthetic agents than these earlier reports, our findings demonstrate the generalized effect of the induction of CTA with different anesthetic agents. In contrast to earlier reports of an induction of CTA with different anesthetics, the findings from our experiments differ from previous reports of a failure to obtain a CTA with Pentobarbitol anesthesia (Rabin & Rabin, 1984) and also differ from reports which have demonstrated an attenuation of CTA with Ketaset (Aguado et aL, 1994). Aguado et aL (1994) and Welzl et aL (1990) reported an attenuation of CTA when Ketaset was injected 30 minutes prior to flavor presentation. When Ketaset is injected prior to the conditioning trial and CTA learning is not manifested, it is plausible that Ketaset blocks processing of the conditioned (flavor) stimulus, thus resulting in an attenuated or retarded CTA effect. We did not administer Ketaset prior to the conditioning trial, but instead, incorporated Ketaset as part of the conditioning agent. In any event, whether administration of Ketaset prior to conditioning would block the induction of Ketaset-Rompun-induced CTA in our paradigm remains to be determined. One unexpected result from Experiment 2 was the finding that the 2hr delay between the CS and the US produced the strongest CTA effect. As the strength of taste aversion learning has been reported to decrease as the CS-US interval is lengthened (Garcia et aL, 1966; Kalat & Rozin, 1971; Logue, 1979), it is not clear why the 2-hr delay produced a stronger CTA than the immediate or 1-hr delayed injection in Experiment 2; however, it may reflect an important characteristic of Ketaset-Rompuninduced CTA. Typically, studies that have reported anesthesia-induced CTA have not examined the time-dependent characteristics of this type of learning. Although Bermudez-Rattoni et al. (1988) and Buresova and Bures (1977) reported that the administration of anesthetic agents produced CTA in their preparations, neither investigation reported the time-dependent effects of anesthesia-induced aversions. Therefore, with the lack of evidence reporting the time-dependent functions of anesthesia-induced CTA, we cannot conclude whether the increased CTA at the 2-hr delay in Experiment 2 is specific to Ketaset-Rompuninduced CTA, or if this relationship occurs for other types of anesthetic agents as well. One interpretation of the data from these experiments is that because the retention test occurred after a relatively short time interval (24 hr after conditioning), it is possible that there was a residual effect on fluid consumption that had nothing to do with CTA learning. That is, if subjects injected with Ketaset-Rompun were still under the influence of 480 METZGER ET AL. the drug at the time of testing it may have created a nonspecific effect on consumption that did not reflect taste aversion learning. Although measuring the time required to metabolize the anesthetic was beyond the scope of this study, the subjects did appear to be behaviorally "back to normal" by the time of testing. With the volume of anesthetic injected in the present experiments, the rats typically regained the righting reflex within 1.5 to 2 hr of administration of the drug and displayed normal behavior soon after righting. Additionally, if there was a nonspecific effect of the anesthetic influencing the results in the present study, subjects with a shorter injection-to-testing interval (Le., subjects in the AN-4 and AN-6 groups) should have demonstrated a greater aversion than subjects in the other conditions, as the injection-test interval for the AN-4 and AN-6 groups was shorter than for rats in the other delay conditions. However, statistical analysis confirmed that eTA occurred only with subjects in the AN-O, AN-1, and AN-2 groups, but subjects in the AN-4 and AN-6 groups did not differ from subjects injected with saline on the conditioning day, an effect opposite than would be expected from a nonspecific drug effect interpretation. Therefore, although we cannot entirely rule out a nonspecific drug effect interpretation of the data, such a conclusion does seem unlikely. In this study we did not administer the conditioning agent in a mg/kg injection, but rather we injected all subjects with a constant volume of the drug. This procedural manipulation was utilized in our experiments because of a common method used to administer the anesthetic during surgical preparations. Often, a diluted stock mixture of Ketaset-Rompun anesthesia is formulated, and subjects that are similar in body weight are administered the same volume of the drug. One concern with this approach may be that the amount of eTA produced by the anesthetic in this study may have been dependent on the body weight of the subjects; that is, the drug may have differentially affected subjects of different sizes and weights. However, a correlation computed on the body weights of the subjects and their difference scores for rats immediately injected with the anesthetic revealed that there was absolutely no relationship between body weight and the amount of aversion produced by the drug (r = .00015, p> .05). Had the aversions been dependent on the size of the animals, a significant correlation between body weight and amount of aversion should have been revealed. The results of the present study are of potential importance to researchers using Ketaset-Rompun anesthesia for surgical and/or analgesic purposes in rodent research, especially if flavor presentations or the eTA paradigm are to be incorporated in the experimental design. These data indicate that injections of Ketaset-Rompun anesthesia can induce taste aversions to novel flavors that are presented in close temporal proximity to administration of the anesthetic, a finding that may offer alternative explanations to the results of studies employing this pharmacological agent. Although other studies have investigated the specific effects (onset, duration, recovery time, etc.) of Ketaset-Rompun ANESTHESIA AND CONDITIONED TASTE AVERSION 481 anesthesia (Wixson et aI., 1987), this is the first study examining the behavioral effects of administration of this drug. Because this study demonstrated that Ketaset-Rompun-induced eTA did not follow the characteristic time-dependent function of taste aversion learning, other anomalies of this drug may become evident as more research is conducted with Ketaset-Rompun. Until more is known about the consequences of utilizing this anesthetic in learning experiments, researchers incorporating this drug should consider the possible behavioral effects of Ketaset-Rompun administration in their research. References AGUADO, L., SAN ANTONIO, A., PEREZ, L., DEL VALLE, R., & GOMEZ, J. (1994). Effects of the NMDA receptor antagonist Ketamine on flavor memory: Conditioned aversion, latent inhibition, and habituation of neophobia. Behavioral and Neural Biology, 61,271-281. BURESOVA, 0., & BURES, J. (1977). The effect of anesthesia on acquisition and extinction of conditioned taste aversion. Behavioral Biology, 20, 41-50. BERMUDEZ-RATTONI, F., FORTHMAN, D. L., SANCHEZ, M. A., PEREZ, J. L., & GARCIA, J. (1988). Odor and taste aversions conditioned in anesthetized rats. Behavioral Neuroscience, 102(5}, 726-732. GARCIA, J., ERVIN, F. R., & KOELLING, R. A. (1966). Learning with prolonged delay of reinforcement. Psychonomic Science, 5,121-122. KALAT, J. W., & ROZIN, P. (1971). Role of interference in taste aversion learning. Journal of Comparative and Physiological Psychology, 77, 53-58. LOGUE, A. W. (1979). Taste aversion and the generality of the laws of learning. Psychological Bulletin, 86(2}, 276-296. RABIN, B. M., & RABIN, J. S. (1984). Acquisition of radiation- and lithium chloride-induced conditioned taste aversions in anesthetized rats. Animal Learning & Behavior, 12, 439-441 . WELZL, H., ALESSANDRI, B., & BATTIG, K. (1990). The formation of a new gustatory memory trace in rats is prevented by the noncompetitive NMDA antagonist ketamine. Psychobiology, 18(1),43-47. WIXSON, S. K., WHITE, W. J., HUGHES, H. C., JR., LANG, C. M., & MARSHALL, W. K. (1987). A comparison of Pentobarbital, FentanylDroperidol, Ketamine-Xylazine, and Ketamine-Diazepam anesthesia in adult male rats. Laboratory Animal Sciences, 37(6}, 726-730. 482 METZGER ET AL.